Inactive Ingredient Search for Approved Drug Products
You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with B
| Quarter | Inactive Ingredient | Route of Administration | Dosage Form | Maximum Potency per unit dose | Maximum Daily Exposure | Status | |
|---|---|---|---|---|---|---|---|
| Q3 2024 | BENZYL ALCOHOL | INTRABURSAL | INJECTION | 1.00 %w/v | Deletion | ||
| Q3 2024 | BUTYLATED HYDROXYANISOLE | ORAL | CAPSULE, GELATIN COATED | 0.07 mg | Deletion | ||
| Q3 2024 | BUTYLATED HYDROXYTOLUENE | TRANSDERMAL | GEL | 0.05 %w/w | Deletion | ||
| Q2 2024 | BENZALKONIUM CHLORIDE | NASAL | SPRAY, METERED | 0.70 mg/ 1.00 ml | MDE Replacement | ||
| Q3 2024 | BENZALKONIUM CHLORIDE | NASAL | SPRAY, METERED | 1mg | MDE Replacement | ||
| Q2 2024 | BENZYL ALCOHOL | TOPICAL | LOTION | 2.00 %w/w | MDE Replacement | ||
| Q3 2024 | BENZYL ALCOHOL | TOPICAL | LOTION | 4000mg | MDE Replacement | ||
| Q2 2024 | BUTYLATED HYDROXYTOLUENE | TOPICAL | AEROSOL, FOAM | 0.10 %w/w | MDE Replacement | ||
| Q3 2024 | BUTYLATED HYDROXYTOLUENE | TOPICAL | AEROSOL, FOAM | 4mg | MDE Replacement | ||
| Q2 2024 | BUTYLATED HYDROXYTOLUENE | TOPICAL | LOTION | 0.50 %w/w | MDE Replacement | ||
| Q3 2024 | BUTYLATED HYDROXYTOLUENE | TOPICAL | LOTION | 1000mg | MDE Replacement | ||
| Q2 2024 | BUTYLATED HYDROXYTOLUENE | TOPICAL | SOLUTION | 0.09 %w/v | MDE Replacement | ||
| Q3 2024 | BUTYLATED HYDROXYTOLUENE | TOPICAL | SOLUTION | 3mg | MDE Replacement |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: July 3, 2024
Database Last Updated: July 31, 2024